JCEM:初潮和绝经延迟与心血管病低风险相关

2013-03-11 高晓方 译 医学论坛网

  中国学者的一项研究表明,初潮和绝经年龄与糖尿病无相关性;初潮和绝经延迟与心血管疾病风险降低相关,早期绝经则与骨质疏松风险升高相关。论文于2013年3月7日在线发表于《临床内分泌学与代谢杂志》(J Clin Endocr Metab)。   此项基于人群的横断面研究对6242例年龄为21至92岁的受试者进行了评估,在排除绝经前女性、未报告初潮和绝经年龄者、未报告体

  中国学者的一项研究表明,初潮和绝经年龄与糖尿病无相关性;初潮和绝经延迟与心血管疾病风险降低相关,早期绝经则与骨质疏松风险升高相关。论文于2013年3月7日在线发表于《临床内分泌学与代谢杂志》(J Clin Endocr Metab)。

  此项基于人群的横断面研究对6242例年龄为21至92岁的受试者进行了评估,在排除绝经前女性、未报告初潮和绝经年龄者、未报告体检指标者以及初潮年龄<8岁或>20岁者之后,共纳入3304例绝经后受试者。在受试者中实施口服糖耐量试验、12导联静息心电图和跟骨定量超声检查。

  结果显示,初潮年龄、糖尿病和骨质疏松之间无显著相关性。初潮延迟(>18岁)与心血管疾病风险降低显著相关(比值比[OR] 0.71;P=0.002)。绝经年龄与糖尿病无相关性;延迟绝经与心血管疾病风险降低相关,早期绝经(≤46岁)则与骨质疏松风险升高相关(OR 1.59;P=0.023)。


Associations Between Age at Menarche and Menopause With Cardiovascular Disease, Diabetes, and Osteoporosis in Chinese Women

Context: Ages at menarche and menopause are associated with cardiovascular disease (CVD), diabetes, and osteoporosis in Caucasian women, but associations remain unexplored in Chinese women.

Objective: The purpose of this study was to assess associations between age at menarche and menopause with CVD, diabetes, and osteoporosis in Chinese women.

Design and Setting: A cross-sectional, population-based study was conducted in Fujian, China, from June 2011 to January 2012.

Participants: Among 6242 women aged 21 to 92 years, 3304 postmenopausal women were enrolled, excluding premenopausal women (n = 2527), those with unreported ages at menarche and menopause (n = 138), those with unrecorded physical measurements (n = 203), and those with menarche age <8 years or >20 years (n = 70).

Main Outcome Measures: An oral glucose tolerance test, a 12-lead resting electrocardiogram, and calcaneus quantitative ultrasound were performed.

Results: No significant associations were found between menarche age, diabetes, and osteoporosis (both P > .05); later menarche (>18 years) was significantly associated with lower CVD risk (odds ratio = 0.71, 95% confidence interval, 0.57–0.89; P = .002). Menopause age was not associated with diabetes; higher menopause age was associated with decreasing CVD risk (Pfor trend = .020) and earlier menopause (≤46 years) with significantly higher osteoporosis risk (odds ratio = 1.59, 95% confidence interval, 1.07–2.36; P = .023).

Conclusions: In China, ages at menarche and menopause are not associated with diabetes. Later menarche and menopause are associated with decreasing CVD risk and earlier menopause with higher osteoporosis risk. Menarche and menopause history may help identify women with increased risk of developing CVD and osteoporosis.


    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1644365, encodeId=4a231644365d3, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Sat Jul 27 15:13:00 CST 2013, time=2013-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062759, encodeId=a4ae2062e598a, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sat Jul 20 13:13:00 CST 2013, time=2013-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777383, encodeId=3cf81e77383b0, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Tue Dec 10 20:13:00 CST 2013, time=2013-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677680, encodeId=4bf716e76802e, content=<a href='/topic/show?id=53fb32222ca' target=_blank style='color:#2F92EE;'>#初潮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32222, encryptionId=53fb32222ca, topicName=初潮)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74f427571521, createdName=zhucaizhong7775, createdTime=Tue Jul 30 23:13:00 CST 2013, time=2013-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256977, encodeId=0f8212569e71d, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Wed Mar 13 04:13:00 CST 2013, time=2013-03-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1644365, encodeId=4a231644365d3, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Sat Jul 27 15:13:00 CST 2013, time=2013-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062759, encodeId=a4ae2062e598a, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sat Jul 20 13:13:00 CST 2013, time=2013-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777383, encodeId=3cf81e77383b0, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Tue Dec 10 20:13:00 CST 2013, time=2013-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677680, encodeId=4bf716e76802e, content=<a href='/topic/show?id=53fb32222ca' target=_blank style='color:#2F92EE;'>#初潮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32222, encryptionId=53fb32222ca, topicName=初潮)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74f427571521, createdName=zhucaizhong7775, createdTime=Tue Jul 30 23:13:00 CST 2013, time=2013-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256977, encodeId=0f8212569e71d, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Wed Mar 13 04:13:00 CST 2013, time=2013-03-13, status=1, ipAttribution=)]
    2013-07-20 achengzhao
  3. [GetPortalCommentsPageByObjectIdResponse(id=1644365, encodeId=4a231644365d3, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Sat Jul 27 15:13:00 CST 2013, time=2013-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062759, encodeId=a4ae2062e598a, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sat Jul 20 13:13:00 CST 2013, time=2013-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777383, encodeId=3cf81e77383b0, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Tue Dec 10 20:13:00 CST 2013, time=2013-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677680, encodeId=4bf716e76802e, content=<a href='/topic/show?id=53fb32222ca' target=_blank style='color:#2F92EE;'>#初潮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32222, encryptionId=53fb32222ca, topicName=初潮)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74f427571521, createdName=zhucaizhong7775, createdTime=Tue Jul 30 23:13:00 CST 2013, time=2013-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256977, encodeId=0f8212569e71d, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Wed Mar 13 04:13:00 CST 2013, time=2013-03-13, status=1, ipAttribution=)]
    2013-12-10 smallant2015
  4. [GetPortalCommentsPageByObjectIdResponse(id=1644365, encodeId=4a231644365d3, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Sat Jul 27 15:13:00 CST 2013, time=2013-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062759, encodeId=a4ae2062e598a, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sat Jul 20 13:13:00 CST 2013, time=2013-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777383, encodeId=3cf81e77383b0, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Tue Dec 10 20:13:00 CST 2013, time=2013-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677680, encodeId=4bf716e76802e, content=<a href='/topic/show?id=53fb32222ca' target=_blank style='color:#2F92EE;'>#初潮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32222, encryptionId=53fb32222ca, topicName=初潮)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74f427571521, createdName=zhucaizhong7775, createdTime=Tue Jul 30 23:13:00 CST 2013, time=2013-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256977, encodeId=0f8212569e71d, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Wed Mar 13 04:13:00 CST 2013, time=2013-03-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1644365, encodeId=4a231644365d3, content=<a href='/topic/show?id=e3eb89e17fb' target=_blank style='color:#2F92EE;'>#血管病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89717, encryptionId=e3eb89e17fb, topicName=血管病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=64bb23195917, createdName=Luyuxie_17, createdTime=Sat Jul 27 15:13:00 CST 2013, time=2013-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2062759, encodeId=a4ae2062e598a, content=<a href='/topic/show?id=14fb10264d7' target=_blank style='color:#2F92EE;'>#JCE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10264, encryptionId=14fb10264d7, topicName=JCE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e656479, createdName=achengzhao, createdTime=Sat Jul 20 13:13:00 CST 2013, time=2013-07-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1777383, encodeId=3cf81e77383b0, content=<a href='/topic/show?id=eb9610265ed' target=_blank style='color:#2F92EE;'>#JCEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10265, encryptionId=eb9610265ed, topicName=JCEM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a4439169927, createdName=smallant2015, createdTime=Tue Dec 10 20:13:00 CST 2013, time=2013-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677680, encodeId=4bf716e76802e, content=<a href='/topic/show?id=53fb32222ca' target=_blank style='color:#2F92EE;'>#初潮#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32222, encryptionId=53fb32222ca, topicName=初潮)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74f427571521, createdName=zhucaizhong7775, createdTime=Tue Jul 30 23:13:00 CST 2013, time=2013-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256977, encodeId=0f8212569e71d, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Wed Mar 13 04:13:00 CST 2013, time=2013-03-13, status=1, ipAttribution=)]

相关资讯

Diabetologia:初潮年纪小增加患糖尿病风险

12月22日,德国亥姆霍兹慕尼黑中心发布研究成果称,女孩第一次来月经的时间越早,将来可能患上前驱糖尿病或糖尿病的风险就越高。研究论文发表在Diabetologia上。 亥姆霍兹慕尼黑中心(即德国健康与环境研究中心)的科学家基于对从KORA队列夺取的数据分析得出了该结论。研究者希望该研究在将来能有助于发现更好的方法来预防这些疾病。 将来,根据女性第一次来月经的时间即有可能检测出她可能患上糖尿病的